Company Filing History:
Years Active: 2009
Title: Innovations by Shengwin Li: A Pioneer in Neurotoxin Research
Introduction: Shengwin Li, based in Irvine, California, is an innovative inventor with a notable contribution to the field of neurotoxin derivatives. His work focuses on developing therapeutic compositions aimed at treating various disorders affecting the sensory and motor nervous systems, among other conditions.
Latest Patents: Shengwin Li holds a patent for "Multivalent Clostridial toxin derivatives and methods of their use." This invention introduces multivalent neurotoxin derivatives designed with multiple binding domains that target specific cell surface features of diseased cells. The therapeutic applications of these modified neurotoxins are vast, as they serve to prevent exocytosis and secretion in target cells. Conditions treatable with this innovation include chronic pain, cancer, hyperhidrosis, and cystic fibrosis, showcasing its potential in transformative medical treatments.
Career Highlights: Currently, Shengwin Li is affiliated with Allergan, Inc., a leading company in the pharmaceutical and aesthetic healthcare sector. His dedication to research and development has resulted in significant advancements in neurotoxin applications within the medical field, positioning him as a key figure in this specialty.
Collaborations: Throughout his career, Li has collaborated with esteemed colleagues, including Lance Steward and Fernandez-Salas Ester. These partnerships have fostered an environment of innovation and knowledge sharing, contributing further to the development of effective therapeutic solutions.
Conclusion: Shengwin Li exemplifies the spirit of innovation in the field of therapeutic science. His patented work with neurotoxin derivatives not only opens new avenues for treatment but also highlights the importance of collaborative efforts in advancing health-related technologies. As he continues his research at Allergan, Inc., the future looks promising for therapeutic interventions that arise from his pioneering inventions.